Mesenchymal stem cell-like cells derived from mouse induced pluripotent stem cells ameliorate diabetic polyneuropathy in mice

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Himeno, Tatsuhito ^a   Kamiya, Hideki ^a,b   Naruse, Keiko ^c   Cheng, Zhao ^a   Ito, Sachiko ^a   Kondo, Masaki ^a   Okawa, Tetsuji ^a   Fujiya, Atsushi ^a   Kato, Jiro ^a   Suzuki, Hirohiko ^a   Kito, Tetsutaro ^a   Hamada, Yoji ^a   Oiso, Yutaka ^a   Isobe, Kenichi ^a   Nakamura, Jiro ^b  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID; ANGIOGENIC FACTOR; BETA GALACTOSIDASE; BIOLOGICAL MARKER; CDKN2A PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; GREEN FLUORESCENT PROTEIN; NERVE GROWTH FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; FLOW CYTOMETRY; HINDLIMB; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NERVE CONDUCTION; NONHUMAN; PERCEPTIVE THRESHOLD; PERIPHERAL NERVE; PLURIPOTENT STEM CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN BLOOD FLOW; ANIMAL; BLOOD FLOW; BODY WEIGHT; CAPILLARY; CELL AGING; CELL DIFFERENTIATION; CYTOLOGY; GLUCOSE BLOOD LEVEL; LIMB; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PERCEPTION; SKELETAL MUSCLE; SKIN; VASCULARIZATION;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; BETA-GALACTOSIDASE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY WEIGHT; CAPILLARIES; CELL AGING; CELL DIFFERENTIATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DIABETIC NEUROPATHIES; EXTREMITIES; GREEN FLUORESCENT PROTEINS; INDUCED PLURIPOTENT STEM CELLS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MUSCLE FIBERS, SKELETAL; NERVE GROWTH FACTORS; NEURAL CONDUCTION; PERCEPTION; PERIPHERAL NERVES; REGIONAL BLOOD FLOW; SKIN;

EID: 84890096899     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/259187     Document Type: Article

References (42)

1. English K., French A., Wood K. J., Mesenchymal stromal cells: facilitators of successful transplantation? Cell Stem Cell 2010 7 4 431 442 2-s2.0-77957338676 10.1016/j.stem.2010.09.009
2. Wilson D. K., Bohren K. M., Gabbay K. H., Quiocho F. A., An unlikely sugar substrate site in the 1.65 Å structure of the human aldose reductase holoenzyme implicated in diabetic complications. Science 1992 257 5066 81 84 2-s2.0-0026719692
3. +-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2. Journal of Clinical Investigation 1995 96 2 733 740 2-s2.0-0029087910
4. Ishii H., Jirousek M. R., Koya D., Takagi C., Xia P., Clermont A., Bursell S.-E., Kern T. S., Ballas L. M., Heath W. F., Stramm L. E., Feener E. P., King G. L., Amelioration of vascular dysfunctions in diabetic rats by an oral PKC β inhibitor. Science 1996 272 5262 728 731 2-s2.0-13344293711 (Pubitemid 26000279)
5. Craven P. A., Studer R. K., DeRubertis F. R., Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats. Evidence for protein kinase C-mediated suppression of the cholinergic response. Journal of Clinical Investigation 1994 93 1 311 320 2-s2.0-0028039015
6. Koya D., King G. L., Protein kinase C activation and the development of diabetic complications. Diabetes 1998 47 6 859 866 2-s2.0-0031860340 10.2337/diabetes.47.6.859 (Pubitemid 28255657)
7. Cameron N. E., Cotter M. A., Archibald V., Dines K. C., Maxfield E. K., Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats. Diabetologia 1994 37 5 449 459 2-s2.0-0028207046 (Pubitemid 24133646)
8. Coppey L. J., Gellett J. S., Davidson E. P., Dunlap J. A., Lund D. D., Yorek M. A., Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes 2001 50 8 1927 1937 2-s2.0-0035430412 (Pubitemid 33641615)
9. Garcia Soriano F., Virág L., Jagtap P., Szabó É., Mabley J. G., Liaudet L., Marton A., Hoyt D. G., Murthy K. G. K., Salzman A. L., Southan G. J., Szabó C., Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nature Medicine 2001 7 1 108 113 2-s2.0-0035136240 10.1038/83241 (Pubitemid 32095649)
10. Horie K., Miyata T., Maeda K., Miyata S., Sugiyama S., Sakai H., Van Ypersele De Strihou C., Monnier V. M., Witztum J. L., Kurokawa K., Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. Journal of Clinical Investigation 1997 100 12 2995 3004 2-s2.0-0031453830 (Pubitemid 28022836)
11. Giardino I., Edelstein D., Brownlee M., Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes. Journal of Clinical Investigation 1994 94 1 110 117 2-s2.0-0028304845
12. Shinohara M., Thornalley P. J., Giardino I., Beisswenger P., Thorpe S. R., Onorato J., Brownlee M., Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. Journal of Clinical Investigation 1998 101 5 1142 1147 2-s2.0-0032032578 (Pubitemid 28125293)
13. Schmidt A. M., Hori O., Jing Xian Chen J. X. C., Jian Feng Li J. F. L., Crandall J., Zhang J., Cao R., Shi Du Yan S. D. Y., Brett J., Stern D., Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice: a potential mechanism for the accelerated vasculopathy of diabetes. Journal of Clinical Investigation 1995 96 3 1395 1403 2-s2.0-0029088742
14. Lu M., Kuroki M., Amano S., Tolentino M., Keough K., Kim I., Bucala R., Adamis A. P., Advanced glycation end products increase retinal vascular endothelial growth factor expression. Journal of Clinical Investigation 1998 101 6 1219 1224 2-s2.0-0032520871 (Pubitemid 28145237)
15. Cameron N. E., Eaton S. E. M., Cotter M. A., Tesfaye S., Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 2001 44 11 1973 1988 2-s2.0-0035195970 10.1007/s001250100001 (Pubitemid 33124042)
16. Hinder L. M., Vincent A. M., Burant C. F., Pennathur S., Feldman E. L., Bioenergetics in diabetic neuropathy: what we need to know. Journal of the Peripheral Nervous System 2012 17 Supplement s2 10 14 2-s2.0-84860605076 10.1111/j.1529-8027.2012.00389.x
17. Lupachyk S., Watcho P., Hasanova N., Julius U., Obrosova I. G., Triglyceride, nonesterified fatty acids, and prediabetic neuropathy: role for oxidative-nitrosative stress. Free Radical Biology and Medicine 2012 52 8 1255 1263 2-s2.0-84857949744 10.1016/j.freeradbiomed.2012.01.029
18. Shibata T., Naruse K., Kamiya H., Kozakae M., Kondo M., Yasuda Y., Nakamura N., Ota K., Tosaki T., Matsuki T., Nakashima E., Hamada Y., Oiso Y., Nakamura J., Transplantation of bone marrow-derived mesenchymal stem cells improves diabetic polyneuropathy in rats. Diabetes 2008 57 11 3099 3107 2-s2.0-58149337284 10.2337/db08-0031
19. Naruse K., Hamada Y., Nakashima E., Kato K., Mizubayashi R., Kamiya H., Yuzawa Y., Matsuo S., Murohara T., Matsubara T., Oiso Y., Nakamura J., Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy. Diabetes 2005 54 1823 1828 2-s2.0-33746871779 (Pubitemid 40770773)
20. Jeong J.-O., Kim M.-O., Kim H., Lee M.-Y., Kim S.-W., Ii M., Lee J.-U., Lee J., Choi Y. J., Cho H.-J., Lee N., Silver M., Wecker A., Kim D.-W., Yoon Y.-S., Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy. Circulation 2009 119 5 699 708 2-s2.0-61549105902 10.1161/CIRCULATIONAHA.108.789297
21. Kim H., Park J.-S., Yong J. C., Kim M.-O., Yang H. H., Kim S.-W., Ji W. H., Lee J., Kim S., Houge M. A., Ii M., Yoon Y.-S., Bone marrow mononuclear cells have neurovascular tropism and improve diabetic neuropathy. Stem Cells 2009 27 7 1686 1696 2-s2.0-68049147746 10.1002/stem.87
22. Okawa T., Kamiya H., Himeno T., Kato J., Seino Y., Transplantation of neural crest like cells derived from induced pluripotent stem cells improves diabetic polyneuropathy in mice. Cell Transplantation 2013 22 10 1767 1783 10. 3727/096368912X657710
23. Takahashi K., Yamanaka S., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006 126 4 663 676 2-s2.0-33747195353 10.1016/j.cell.2006.07.024 (Pubitemid 44233629)
24. Awaya T., Kato T., Mizuno Y., Chang H., Niwa A., Selective development of myogenic mesenchymal cells from human embryonic and induced pluripotent stem cells. PLoS ONE 2012 7 e51638
25. Chen Y. S., Pelekanos R. A., Ellis R. L., Horne R., Wolvetang E. J., Small molecule mesengenic induction of human induced pluripotent stem cells to. Stem Cells Translational Medicine 2012 1 83 95
26. Eberle I., Moslem M., Henschler R., Cantz T., Engineered MSCs from patient-specific iPS cells. Advances in Biochemical Engineering/Biotechnology 2012 10.1007/10-2012-156
27. 2+ channel activity and its control by M4 muscarinic receptors in primary sensory neurons. Journal of Neurochemistry 2011 119 3 594 603 2-s2.0-80054074898 10.1111/j.1471-4159.2011.07456.x
28. Williams R. L., Hilton D. J., Pease S., Wilson T. A., Stewart C. L., Gearing D. P., Wagner E. F., Metcalf D., Nicola N. A., Gough N. M., Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 1988 336 6200 684 687 2-s2.0-0024205842 (Pubitemid 19007951)
29. Chateauvieux S., Ichanté J.-L., Delorme B., Frouin V., Piétu G., Langonné A., Gallay N., Sensebé L., Martin M. T., Moore K. A., Charbord P., Molecular profile of mouse stromal mesenchymal stem cells. Physiological Genomics 2007 29 2 128 138 2-s2.0-34247857374 10.1152/physiolgenomics.00197.2006 (Pubitemid 46701994)
30. Chopp M., Li Y., Treatment of neural injury with marrow stromal cells. The Lancet Neurology 2002 1 2 92 100 2-s2.0-0013278301 10.1016/S1474-4422(02) 00040-6 (Pubitemid 37163494)
31. Katims J. J., Naviasky E. H., Ng L. K. Y., New screening device for assessment of peripheral neuropathy. Journal of Occupational Medicine 1986 28 12 1219 1221 2-s2.0-0022910563 (Pubitemid 17229061)
32. Neirinckx V., Coste C., Rogister B., Wislet-Gendebien S., Concise review: adult mesenchymal stem cells, adult neural crest stem cells, and therapy of neurological pathologies: a state of play. Stem Cells Translational Medicine 2013 2 284 296
33. Houlihan D. D., Mabuchi Y., Morikawa S., Niibe K., Araki D., Isolation of mouse mesenchymal stem cells on the basis of expression of Sca-1 and PDGFR-alpha. Nature Protocols 2012 7 2103 2111
34. Hare J. M., Fishman J. E., Gerstenblith G., DiFede Velazquez D. L., Zambrano J. P., Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells. Journal of the American Medical Association 2012 308 2369 2379
35. Chou S. H., Lin S. Z., Day C. H., Kuo W. W., Shen C. Y., Mesenchymal stem cell insights: prospects in hematologic transplantation. Cell Transplantation 2013 22 4 711 721 10. 3727/096368912x655172
36. Zhang Y., Liao S., Yang M., Liang X., Poon M. W., Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension. Cell Transplantation 2012 21 2225 2239
37. Brown K., Xie S., Qiu X., Mohrin M., Shin J., SIRT3 reverses aging-associated degeneration. Cell Reports 2013 3 319 327
38. Carlson M. E., Suetta C., Conboy M. J., Aagaard P., Mackey A., Kjaer M., Conboy I., Molecular aging and rejuvenation of human muscle stem cells. EMBO Molecular Medicine 2009 1 8-9 381 391 2-s2.0-77951664071 10.1002/emmm.200900045
39. Banito A., Gil J., Induced pluripotent stem cells and senescence: learning the biology to improve the technology. EMBO Reports 2010 11 5 353 359 2-s2.0-77951878056 10.1038/embor.2010.47
40. Lapasset L., Milhavet O., Prieur A., Besnard E., Babled A., Ät-Hamou N., Leschik J., Pellestor F., Ramirez J.-M., De Vos J., Lehmann S., Lemaitre J.-M., Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state. Genes and Development 2011 25 21 2248 2253 2-s2.0-80455144472 10.1101/gad.173922.111
41. Pan Y., Cai S., Current state of the development of mesenchymal stem cells into clinically applicable Schwann cell transplants. Molecular and Cellular Biochemistry 2012 368 127 135
42. Terashima T., Kojima H., Fujimaya M., Matsumura K., Oi J., Hara M., Kashiwagi A., Kimura H., Yasuda H., Chan L., The fusion of bone-marrow-derived proinsulin-expressing with nerve cells underlies diabetic neuropathy. Proceedings of the National Academy of Sciences of the United States of America 2005 102 35 12525 12530 2-s2.0-24644448791 10.1073/pnas.0505717102 (Pubitemid 41266392)